Dianthus Therapeutics, Inc. (DNTH) NASDAQ
87.48
+1.28(+1.48%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
87.48
+1.28(+1.48%)
Currency In USD
| Market Cap | 1.56B |
| Enterprise Value | 1.51B |
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1,650.57 |
| Price/Book Ratio | 6.7 |
| Enterprise/Revenue | 1,626.15 |
| Enterprise/EBITDA | -19.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | -87.39 |
| Return On Assets | 0 |
| Return On Equity | 0 |
| Revenue | 2.04M |
| Revenue/Share | 0.05 |
| Gross Profit | 2.04M |
| EBITDA | -177.93M |
| Net Income | -162.34M |
| Diluted EPS | -4.2 |
| Total Cash | 404.3M |
| Total Cash/Share | 10.7 |
| Total Debt | 1.39M |
| Total Debt/Equity | 0 |
| Current Ratio | 13.32 |
| Book Value Per Share | 13.05 |
| 52-Week Change | 488.69 |
| 52-Week High | 89.72 |
| 52-Week Low | 13.37 |
| Moving Average 50 Days | 63.91 |
| Moving Average 200 Days | 40.24 |
| Average Volume | 1.1M |
| Shares Outstanding | 38.42M |
| % Held by Institutions | 129.97 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | September 12, 2023 |